SCHEMBL1498448

SCHEMBL1498448

O=C(O)N[C@H]1C[C@H](CSc2cccc(C(F)(F)F)c2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.48
POLB P06746 3/20 0.48
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPT P10636 2/20 0.42
PTGER1 P34995 1/20 0.42
PTGFR P43088 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
USP2 O75604 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SMYD3 Q9H7B4 1/20 0.40
SIGMAR1 Q99720 2/20 0.39
EPHX2 P34913 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
HTT P42858 1/20 0.38
XBP1 P17861 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1498447 1.00 GAA (0.48) GAAPOLBALDH1A1KDM4EATM
SCHEMBL10476100 0.89 POLB (0.47) GAAPOLBALDH1A1KDM4EATM
SCHEMBL1498410 0.89 POLB (0.47) GAAPOLBALDH1A1KDM4EATM
SCHEMBL10476058 0.89 POLB (0.47) GAAPOLBALDH1A1KDM4EATM
SCHEMBL1498455 0.84 RORC (0.44) GAAPOLBALDH1A1KDM4EATM
SCHEMBL1498454 0.84 RORC (0.44) GAAPOLBALDH1A1KDM4EATM
SCHEMBL1498502 0.81 MEN1 (0.44) GAAPOLBALDH1A1KDM4EATM
SCHEMBL1498500 0.81 MEN1 (0.44) GAAPOLBALDH1A1KDM4EATM
SCHEMBL1498619 0.76 CCR2 (0.50) POLB
SCHEMBL1498620 0.76 CCR2 (0.50) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2477963-A1 ARYL SULPHONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS Zalicus Pharmaceuticals Ltd. (CA) 2012-07-25 EP disclosed
WO-2011035159-A1 ARYL SULPHONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS ZALICUS PHARMACEUTICALS LTD. (CA) 2011-03-24 WO disclosed